Raymond James & Associates’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $37.2M | Buy |
192,065
+6,384
| +3% | +$1.24M | 0.02% | 548 |
|
|
2024
Q2 | $43M | Buy |
185,681
+17,557
| +10% | +$4.07M | 0.03% | 457 |
|
|
2024
Q1 | $36.3M | Buy |
168,124
+26,048
| +18% | +$5.62M | 0.02% | 510 |
|
|
2023
Q4 | $36.8M | Sell |
142,076
-10,184
| -7% | -$2.64M | 0.03% | 494 |
|
|
2023
Q3 | $39.1M | Buy |
152,260
+8,029
| +6% | +$2.06M | 0.03% | 424 |
|
|
2023
Q2 | $41.1M | Buy |
144,231
+23,814
| +20% | +$6.78M | 0.03% | 416 |
|
|
2023
Q1 | $33.5M | Sell |
120,417
-1,067
| -0.9% | -$297K | 0.03% | 481 |
|
|
2022
Q4 | $33.6M | Sell |
121,484
-3,259
| -3% | -$902K | 0.03% | 457 |
|
|
2022
Q3 | $33.3M | Sell |
124,743
-2,323
| -2% | -$620K | 0.03% | 424 |
|
|
2022
Q2 | $25.9M | Sell |
127,066
-9,696
| -7% | -$1.98M | 0.03% | 517 |
|
|
2022
Q1 | $28.8M | Buy |
136,762
+4,480
| +3% | +$943K | 0.02% | 545 |
|
|
2021
Q4 | $31.7M | Sell |
132,282
-18,700
| -12% | -$4.49M | 0.03% | 531 |
|
|
2021
Q3 | $42.7M | Buy |
150,982
+13,546
| +10% | +$3.83M | 0.04% | 405 |
|
|
2021
Q2 | $47.6M | Sell |
137,436
-2,448
| -2% | -$848K | 0.04% | 362 |
|
|
2021
Q1 | $39.1M | Sell |
139,884
-1,065
| -0.8% | -$298K | 0.04% | 390 |
|
|
2020
Q4 | $34.5M | Sell |
140,949
-9,913
| -7% | -$2.43M | 0.04% | 407 |
|
|
2020
Q3 | $42.8M | Sell |
150,862
-15,432
| -9% | -$4.38M | 0.05% | 284 |
|
|
2020
Q2 | $44.5M | Sell |
166,294
-10,902
| -6% | -$2.92M | 0.06% | 267 |
|
|
2020
Q1 | $56.1M | Sell |
177,196
-159,964
| -47% | -$50.6M | 0.09% | 196 |
|
|
2019
Q4 | $100M | Sell |
337,160
-35,266
| -9% | -$10.5M | 0.13% | 142 |
|
|
2019
Q3 | $86.7M | Sell |
372,426
-3,060
| -0.8% | -$712K | 0.12% | 155 |
|
|
2019
Q2 | $87.8M | Sell |
375,486
-44,543
| -11% | -$10.4M | 0.13% | 146 |
|
|
2019
Q1 | $99.3M | Buy |
420,029
+13,645
| +3% | +$3.23M | 0.15% | 129 |
|
|
2018
Q4 | $122M | Sell |
406,384
-15,168
| -4% | -$4.56M | 0.21% | 92 |
|
|
2018
Q3 | $149M | Buy |
421,552
+2,095
| +0.5% | +$740K | 0.23% | 84 |
|
|
2018
Q2 | $122M | Buy |
419,457
+80,296
| +24% | +$23.3M | 0.2% | 93 |
|
|
2018
Q1 | $92.9M | Buy |
339,161
+3,866
| +1% | +$1.06M | 0.17% | 116 |
|
|
2017
Q4 | $107M | Buy |
335,295
+2,604
| +0.8% | +$830K | 0.2% | 98 |
|
|
2017
Q3 | $104M | Buy |
332,691
+8,622
| +3% | +$2.7M | 0.21% | 98 |
|
|
2017
Q2 | $87.9M | Buy |
324,069
+13,755
| +4% | +$3.73M | 0.19% | 108 |
|
|
2017
Q1 | $84.8M | Buy |
310,314
+22,432
| +8% | +$6.13M | 0.2% | 106 |
|
|
2016
Q4 | $81.6M | Buy |
287,882
+7,774
| +3% | +$2.2M | 0.21% | 99 |
|
|
2016
Q3 | $87.7M | Buy |
280,108
+32,791
| +13% | +$10.3M | 0.24% | 89 |
|
|
2016
Q2 | $59.8M | Buy |
247,317
+2,801
| +1% | +$677K | 0.19% | 111 |
|
|
2016
Q1 | $63.7M | Buy |
244,516
+21,412
| +10% | +$5.57M | 0.22% | 90 |
|
|
2015
Q4 | $68.3M | Buy |
223,104
+11,936
| +6% | +$3.66M | 0.24% | 78 |
|
|
2015
Q3 | $61.6M | Sell |
211,168
-6,261
| -3% | -$1.83M | 0.25% | 80 |
|
|
2015
Q2 | $87.8M | Buy |
217,429
+24,402
| +13% | +$9.86M | 0.34% | 47 |
|
|
2015
Q1 | $81.5M | Buy |
193,027
+16,755
| +10% | +$7.07M | 0.36% | 47 |
|
|
2014
Q4 | $59.8M | Buy |
176,272
+48,776
| +38% | +$16.6M | 0.29% | 62 |
|
|
2014
Q3 | $42.2M | Buy |
127,496
+11,666
| +10% | +$3.86M | 0.24% | 74 |
|
|
2014
Q2 | $36.5M | Buy |
115,830
+18,833
| +19% | +$5.94M | 0.23% | 76 |
|
|
2014
Q1 | $29.7M | Buy |
96,997
+2,902
| +3% | +$888K | 0.2% | 80 |
|
|
2013
Q4 | $26.3M | Buy |
94,095
+9,234
| +11% | +$2.58M | 0.2% | 93 |
|
|
2013
Q3 | $20.4M | Buy |
84,861
+9,119
| +12% | +$2.2M | 0.18% | 110 |
|
|
2013
Q2 | $16.3M | Buy |
+75,742
| New | +$16.3M | 0.15% | 132 |
|